NEW-R Stock Overview
Engages in the hospital and medical trading businesses in Thailand. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Wattana Karnpaet Public Company Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ฿70.00 |
52 Week High | ฿141.50 |
52 Week Low | ฿60.00 |
Beta | 0.63 |
11 Month Change | -22.22% |
3 Month Change | -6.67% |
1 Year Change | n/a |
33 Year Change | 21.74% |
5 Year Change | 38.61% |
Change since IPO | 845.95% |
Recent News & Updates
Recent updates
Shareholder Returns
NEW-R | TH Healthcare | TH Market | |
---|---|---|---|
7D | 9.4% | 0.8% | 1.1% |
1Y | n/a | -10.2% | 2.2% |
Return vs Industry: Insufficient data to determine how NEW-R performed against the TH Healthcare industry.
Return vs Market: Insufficient data to determine how NEW-R performed against the TH Market.
Price Volatility
NEW-R volatility | |
---|---|
NEW-R Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 4.4% |
Market Average Movement | 4.7% |
10% most volatile stocks in TH Market | 10.3% |
10% least volatile stocks in TH Market | 2.4% |
Stable Share Price: NEW-R's share price has been volatile over the past 3 months compared to the TH market.
Volatility Over Time: Insufficient data to determine NEW-R's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1985 | n/a | Phiphat Tangsubkul | www.wattanahospital.net |
Wattana Karnpaet Public Company Limited engages in the hospital and medical trading businesses in Thailand. The company operates a private hospital under the North Eastern Wattana Hospital name. Wattana Karnpaet Public Company Limited was incorporated in 1985 and is based in Udon Thani, Thailand.
Wattana Karnpaet Public Company Limited Fundamentals Summary
NEW-R fundamental statistics | |
---|---|
Market cap | ฿700.00m |
Earnings (TTM) | ฿50.45m |
Revenue (TTM) | ฿492.39m |
13.9x
P/E Ratio1.4x
P/S RatioIs NEW-R overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NEW-R income statement (TTM) | |
---|---|
Revenue | ฿492.39m |
Cost of Revenue | ฿360.78m |
Gross Profit | ฿131.61m |
Other Expenses | ฿81.16m |
Earnings | ฿50.45m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 5.04 |
Gross Margin | 26.73% |
Net Profit Margin | 10.25% |
Debt/Equity Ratio | 1.4% |
How did NEW-R perform over the long term?
See historical performance and comparison